Insights
Blogs
IP NEWS WEEKLY UPDATE – 8 DEC 2021
UpGrad files trademark infringement suit against Scaler: A suit was filed before the Delhi HC…
IP NEWS WEEKLY UPDATE – 6 DEC 2021
Lord of the Rings’ Crypto Blocked under JRR Tolkien’s Trademark Violation: The ‘LORD OF THE…
IP NEWS WEEKLY UPDATE – 25 NOV 2021
YouTube expands guidelines on Copyright infringement detection The number of takedowns of content due to…
IP NEWS WEEKLY UPDATE – 13 NOV 2021
Increase in Global IP Filings despite Economic shutdown due to the pandemic WIPO recently released…
IP NEWS WEEKLY UPDATE – 8 NOV 2021
Financial incentives for certification and Intellectual Property Rights reimbursement scheme notified by the Goa government…
A Case Study on Double Patenting: Astrazeneca AB & ANR. Vs. Intas Pharmaceuticals Limited
In a recent Judgment by Delhi High Court on 20 July, 2021 in Astrazeneca Ab & Anr v. Intas Pharmaceuticals Ltd. the court held against Astrazeneca reaffirming that one product cannot be covered by more than one patent with some significant findings on double patenting.
- Go to the previous page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- …
- 33
- Go to the next page
